Journal of Cystic Fibrosis
Volume 7, Issue 1 , Pages 60-67 , January 2008

A pilot study on the safety and efficacy of a novel antioxidant rich formulation in patients with cystic fibrosis

  • Konstantinos A. Papas

      Affiliations

    • Yasoo Health, Johnson City, TN, USA
    • ,
  • Marci K. Sontag

      Affiliations

    • Department of Pediatrics, University of Colorado Health Sciences Center, Mike McMorris Cystic Fibrosis Center, The Children's Hospital, Denver, Colorado, USA
    • Department of Preventive Medicine and Biometrics, University of Colorado at Denver and Health Sciences Center, Colorado, USA
    • Corresponding Author InformationCorresponding author. Children's Hospital, 1056 East 19th Avenue, Denver, CO 80218, USA.
    • ,
  • Churee Pardee

      Affiliations

    • Department of Pediatrics, University of Colorado Health Sciences Center, Mike McMorris Cystic Fibrosis Center, The Children's Hospital, Denver, Colorado, USA
    • ,
  • Ronald J. Sokol

      Affiliations

    • Department of Pediatrics, University of Colorado Health Sciences Center, Mike McMorris Cystic Fibrosis Center, The Children's Hospital, Denver, Colorado, USA
    • ,
  • Scott D. Sagel

      Affiliations

    • Department of Pediatrics, University of Colorado Health Sciences Center, Mike McMorris Cystic Fibrosis Center, The Children's Hospital, Denver, Colorado, USA
    • ,
  • Frank J. Accurso

      Affiliations

    • Department of Pediatrics, University of Colorado Health Sciences Center, Mike McMorris Cystic Fibrosis Center, The Children's Hospital, Denver, Colorado, USA
    • ,
  • Jeffrey S. Wagener

      Affiliations

    • Department of Pediatrics, University of Colorado Health Sciences Center, Mike McMorris Cystic Fibrosis Center, The Children's Hospital, Denver, Colorado, USA

Received 9 January 2007 ,Revised 23 April 2007 ,Accepted 25 April 2007.

References 

  1. Sokol RJ, Papas AM. Antioxidants and neurological diseases. In:  Papas AM editors. Antioxidant status, diet, nutrition and health. Boca Raton: CRC Press; 1998;p. 567–590
  2. Erdman SH. Nutritional imperatives in cystic fibrosis therapy. Pediatr Ann. 1999;28:129–136
  3. Kalivianakis M, Minich DM, Bijleveld CM, et al. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr. 1999;69:127–134
  4. Feranchak AP, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999;135(5):601–610
  5. Sokol RJ, Osberg I, Sontag MK, Wagener JS. Reduced serum coenzyme Q10 concentrations in children with cystic fibrosis. North American meeting on cystic fibrosis. Pediatr Pulmonol. 2003;36(S25):8–376
  6. Papas KA, Kalbfleisch JH, Mohon RT. Bioavailability of a novel water-soluble vitamin E formulation in malabsorbing patients. Dig. Dis. Sci. in press.
  7. Cantin AM, White TB, Cross CE, Forman HJ, Sokol RJ, Borowitz D. Antioxidants in cystic fibrosis. Conclusions from the CF Antioxidant Workshop, Bethesda, Maryland, November 11–12, 2003. Free Radic Biol Med. 2007;42(1):15–31
  8. Oudshoorn JH, Lecluse AL, van den Berg R, Vaes WH, van der Laag J, Houwen RH. Decreased coenzyme Q10 concentration in plasma of children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43(5):646–650
  9. Lagrange-Puget M, Durieu I, Ecochard R, et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr Pulmonol. 2004;38(1):43–49
  10. Sagel SD, Accurso FJ. Monitoring inflammation in CF. Cytokines. Clin Rev Allergy Immunol. 2002;23(1):41–57
  11. Winklhofer-Roob BM, Puhl H, Khoschsorur G, van't Hof MA, Esterbauer H, Shmerling DH. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. Free Radic Biol Med. 1995;18:849–859
  12. Rust P, Eichler I, Renner S, Elmadfa I. Effects of long-term oral beta-carotene supplementation on lipid peroxidation inpatients with cystic fibrosis. Int J Vitam Nutr Res. 1998;68:83–87
  13. Winklhofer-Roob BM, van't Hof MA, Shmerling DH. Response to oral beta-carotene supplementation in patients with cystic fibrosis: a 16-month follow-up study. Acta Paediatr. 1995;84(10):1132–1136
  14. Lepage G, Champagne J, Ronco N. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr. 1996;64:87–93
  15. Brown RK, Wyatt H, Price JF, Kelly FJ. Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J. 1996;9:334–339
  16. Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr. 2003;77(1):150–159
  17. Renner S, Rath R, Rust P, et al. Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax. 2001;56(1):48–52
  18. Sagel SD, Kapsnew R, Osberg I, Sontag MK, Accurso FJ. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am J Respir Crit Care Med. 2001;164:1425–1431
  19. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27(1):158–163
  20. Kaplan L, Miller JA, Stein EA, Stampfer MJ. Simultaneous, high-performance liquid chromatographic analysis of retinol, tocopherols, lycopene, and alpha- and beta-carotene in serum and plasma. Methods Enzymol. 1990;189:155–167
  21. Johnson EJ, Russell RM. Distribution of orally administered beta-carotene among lipoproteins in healthy men. Am J Clin Nutr. 1992;56(1):128–135
  22. Homnick DN, Spillers CR, Cox SR, et al. Single- and multiple-dose-response relationships of beta-carotene in cystic fibrosis. J Pediatr. 1995;127(3):491–494
  23. Cobanoglu N, Ozcelik U, Gocmen A, Kiper N, Dogru D. Antioxidant effect of beta-carotene in cystic fibrosis and bronchiectasis: clinical and laboratory parameters of a pilot study. Acta Paediatr. 2002;91(7):793–798
  24. Winklhofer-Roob BM. Vitamin E supplementation in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1997;25(1):120–122
  25. Huang SH, Schall JI, Zemel BS, Stallings VA. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr. 2006;148(4):556–559
  26. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci U S A. 1997;94:3217–3222
  27. Singh U, Devaraj S, Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr. 2005;25:151–174[Review]
  28. Kettle AJ, Chan T, Osberg I, et al. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med. 2004;170(12):1317–1323
  29. Starosta V, Rietschel E, Paul K, Baumann U, Griese M. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest. 2006;129(2):431–437

PII: S1569-1993(07)00060-4

doi: 10.1016/j.jcf.2007.05.001

Journal of Cystic Fibrosis
Volume 7, Issue 1 , Pages 60-67 , January 2008

Article Tools

* Image Usage & Resolution